Novavax Logo

Novavax

🇺🇸
NVAX
US6700024010

Novavax is a global biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative vaccines. Utilizing proprietary protein nanoparticle technology, Novavax creates crucial immunizations against severe infectious diseases, including influenza and COVID-19, thereby contributing to global health.

Next Quarterly Earnings

Wednesday, August 12, 2026
CW 33
Pre-Market
In 38 days

Stock Price

All Dates

Company Information

Name
Novavax
Ticker Symbol
NVAX
ISIN
US6700024010
Country
🇺🇸
USA
More Financial Information